Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E13 - Community Screening for NAFLD: What Must Advocates Prove?
Description: The UK's National Institute for Health and Care Excellence (NICE) issues health economics-based decisions on whether therapies and diagnostics should be reimbursed by the British government. In a recent draft guidance titled FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care, NICE has stated that "there is not enough certainty for [using FibroScan to assess liver fibrosis or cirrhosis for adults in primary or community care] to recommend it as a clinically effective and cost saving option for routine use." This episode centers around understanding the draft guidance and what it means for out of hospital...